We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Nanalysis Scientific Corp (NSCI) NPV

Sell:0.97 CAD Buy:1.04 CAD Change: 0.01 CAD (0.99%)
Market closed |  Prices as at close on 17 May 2022 | Switch to live prices |
Sell:0.97 CAD
Buy:1.04 CAD
Change: 0.01 CAD (0.99%)
Market closed |  Prices as at close on 17 May 2022 | Switch to live prices |
Sell:0.97 CAD
Buy:1.04 CAD
Change: 0.01 CAD (0.99%)
Market closed |  Prices as at close on 17 May 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nanalysis Scientific Corp. is a Canada-based company, which develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The Company's NMReady-60 is a full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. It operates through three segments: Nanalysis, RS2D and Corporate. Through its European subsidiary RS2D S.A.S. (RS2D), the Company also manufactures and distributes electronic boards and software are used in NMR and MRI equipment. Its 60 and 100 megahertz (MHz) spectrometers incorporate permanent magnets and require no liquid helium or other cryogens. Its product offerings are based upon its magnet technology, as well as its Cam4 technology. Its devices are used in many industries, such as oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, and law enforcement) as well as government and university research labs.

Contact details

Bay 1, 4600 - 5th Street NE
T2E 7C3
+1 (587) 8990513

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
77.39 million CAD
Shares in issue:
76.62 million
Health Care Equipment
Canadian Venture Exchange
Canadian dollars

Key personnel

  • Sean Krakiwsky
    President, Chief Executive Officer, Founder, Director
  • Luke Caplette
    Chief Financial Officer
  • Julien Mueller
    Chief Technology Officer
  • Garett Leskowitz
    Chief Science Officer
  • Susanne Riegel
    Director of Marketing and Product Manager
  • Neal Gallagher
    Head of Product Development
  • Bruce Lix
    Director of Business Development
  • Greg Mcfeetors
    Head of Manufacturing
  • Heather Phillips
    Director of Operations
  • Matt Zamora
    Sales Manager

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.